TAI · Financial Statements

Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Financial Statements

$30.70 TAI: 1734.TW Market Cap $6.65B

Full income statement, balance sheet, and cash flow statement for Sinphar Pharmaceutical Co.,Ltd. (1734.TW), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio1.86
EV / EBITDA10.58
FCF Yield—
Quick Ratio1.46
Interest Coverage—
Return 1Y14.10%
Return 3Y31.79%
Return 5Y52.70%

Sinphar Pharmaceutical Co.,Ltd. (1734.TW) financials — frequently asked questions

What is 1734.TW EV/EBITDA?

Sinphar Pharmaceutical Co.,Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 10.58.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
1734.TW Overview 1734.TW Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.